Interpretable Deep Learning for Anticancer Peptide Prediction

Interpretable Deep Learning for Anticancer Peptide Prediction

Recent advancements in biotechnology and artificial intelligence have led to significant breakthroughs in drug development, particularly in the realm of anticancer therapeutics. Among these advancements, the research conducted by Lv, Li, and Wang introduces a novel framework named ACP-EPC, which effectively leverages a pre-trained protein language model alongside a multi-view feature extracting strategy. This unprecedented approach aims to enhan…